Citation Impact
Citing Papers
Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients
2001 Standout
The Tissue-Engineered Vascular Graft—Past, Present, and Future
2015 Standout
Current controversies in the management of aortoiliac occlusive disease
1997
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
2016 Standout
Detection of bladder cancer recurrence by microsatellite analysis of urine
1997
Axillofemoral bypass for aortoiliac occlusive disease
2000
Urine markers for detection and surveillance of bladder cancer
2013
Guidelines on Urolithiasis<footref rid="foot01"><sup>1</sup></footref>
2001 Standout
EVALUATION OF URINE N1,N12-DIACETYLSPERMINE AS POTENTIAL TUMOR MARKER FOR URINARY BLADDER CANCER
2006
Photodynamic Therapy
1998 Standout
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
DELAYED GRAFT FUNCTION: RISK FACTORS AND IMPLICATIONS FOR RENAL ALLOGRAFT SURVIVAL1
1997 Standout
Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs
2004 Standout
Risk factors for accelerated atherosclerosis in renal transplant recipients
1988
PROLONGED SKIN ALLOGRAFT SURVIVAL AFTER PHOTODYNAMIC THERAPY ASSOCIATED WITH MODIFICATION OF DONOR SKIN ANTIGENICITY1
1997
Enhanced Selective Lymphatic Delivery of Cyclosporin A by Solubilizers and Intensified Immunosuppressive Activity Against Mice Skin Allograft
1986
Cognitive modulation of pain: how do attention and emotion influence pain processing?
2002 Standout
The accuracy of urinary cytology in daily practice
1999
Interleukin 2 receptor antagonists for renal transplant recipients: a meta-analysis of randomized trials1
2004
Guidelines on Bladder Cancer
2002
Monitoring patients for bladder neoplasms: what can be expected of urinary cytology consultations in clinical practice
1999
Clinically Significant Drug Interactions with Cyclosporin
1996
Transurethral Resection and Surveillance of Bladder Cancer Supported by 5-Aminolevulinic Acid-Induced Fluorescence Endoscopy
1999
Endogenous opiates: 1999
2000
Steroid-Withdrawal at 3 Days After Renal Transplantation with Anti-IL-2 Receptor α Therapy: A Prospective, Randomized, Multicenter Study
2004
A comparative evaluation of externally supported polytetrafluoroethylene axillobifemoral and axillounifemoral bypass grafts
1995
2007 Guideline for the Management of Ureteral Calculi
2007 Standout
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 Standout
Osteomyelitis Due to Mycobacterium haemophilum in a Cardiac Transplant Patient: Case Report and Analysis of Interactions Among Clarithromycin, Rifampin, and Cyclosporine
1997
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
2007 Standout
Infection and Cyclosporine
1989
Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors1
2002 Standout
Immunosuppressive effect of emodin, a free radical generator
1992
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
2006 Standout
Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses
2003
Diagnosis of urothelial carcinoma from urine
2009
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
2004 Standout
Bladder cancer
2016 Standout
Acquired Immune Tolerance to Cadaveric Renal Allografts
1989
Metabolomics: beyond biomarkers and towards mechanisms
2016 Standout
Biomedical applications of collagen
2001 Standout
Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation
2007 Standout
Urine Markers for Bladder Cancer Surveillance: A Systematic Review
2005
Causes of Renal Allograft Loss
1991
Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
2009 Standout
The Impact of HLA Mismatches on the Survival of First Cadaveric Kidney Transplants
1994
Cyclosporine
1989 Standout
Identifying Specific Causes of Kidney Allograft Loss
2009 Standout
Anti‐cancer properties of anthraquinones from rhubarb
2006 Standout
Bladder cancer: Epidemiology, staging and grading, and diagnosis
2005 Standout
Interactions of Cyclosporine with Antimicrobial Agents
1989
The Use of Therapeutic Drug Monitoring to Optimise Immunosuppressive Therapy
1996
Molecular Markers for Bladder Cancer Screening, Early Diagnosis, and Surveillance: The WHO/ICUD Consensus
2014
Percutaneous nephrolithotomy intransplanted kidney
1991
EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
2008 Standout
Hypertension Following Kidney Transplantation
1994
Long-term survival in renal transplant recipients with graft function
2000 Standout
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Cell migration and chimerism after whole-organ transplantation: The basis of graft acceptance
1993 Standout
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery
1997
Hypertension in renal transplant recipients
1987
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Device Drug Delivery to the Eye
1991
Infectious Diseases Society of America Guidelines for the Diagnosis and Treatment of Asymptomatic Bacteriuria in Adults
2005 Standout
Pharmacokinetics of oral cyclosporin a (Sandimmun) in healthy subjects
1986
The medically important aerobic actinomycetes: epidemiology and microbiology
1994 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
New Electrochemiluminescent Immunoassay for the Determination of CYFRA 21-1: Analytical Evaluation and Clinical Diagnostic Performance in Urine Samples of Patients with Bladder Cancer
1999
Electrochemiluminescence (ECL)
2004 Standout
Urological Complications in 1,000 Consecutive Renal Transplant Recipients
1995
Clinical Pharmacokinetics of Cyclosporin
1986
PROGNOSTIC MARKERS IN BLADDER CANCER: A CONTEMPORARY REVIEW OF THE LITERATURE
1998
UROLITHIASIS IN RENAL AND COMBINED PANCREAS/RENAL TRANSPLANT RECIPIENTS
1999
A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
1998 Standout
Hypercholesterolaemia and vascular disease after transplantation
1991 StandoutNobel
Does the Binding of Cyclosporine to Calmodulin Result in Immunosuppression?
1986 Science
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans
1995 Standout
Recommendations for the Outpatient Surveillance of Renal Transplant Recipients
2000
Works of Mark V. Jarowenko being referenced
Results of a Multicenter Trial using the BTA Test to Monitor for and Diagnose Recurrent Bladder Cancer
1995
Improved detection of recurrent bladder cancer using the bard bta stat test
1997
Limited Dose Monoclonal IL‐2R Antibody Induction Protocol after Primary Kidney Transplantation
2002
Salvage of Difficult Transplant Complications by Percutaneous Techniques
1985
Effect of External Pressure on Axillofemoral Bypass Grafts
1981
SEROLOGIC METHODS FOR THE EARLY DIAGNOSIS OF PNEUMOCYSTIS CARINII INFECTION IN RENAL ALLOGRAFT RECIPIENTS
1986
Results of a Multicenter Trial using the BTA Test to Monitor for and Diagnose Recurrent Bladder Cancer
1995
The antagonistic effect of rifampin upon cyclosporine bioavailability.
1984
Influence of Cyclosporine on Posttransplant Blood Pressure Response
1987
Clinical and experimental studies with cyclosporine in renal transplantation.
1985
The value of serial serum trough cyclosporine levels in human renal transplantation.
1984
HUMAN RENAL CELL CANCER PROLIFERATION IN TISSUE CULTURE IS TONICALLY INHIBITED BY OPIOID GROWTH FACTOR
1999
Impact of Cyclosporine on Renal Transplant Practice at the University of Texas Medical School at Houston
1985